Prevention

This comprehensive plan for health care professionals and policy makers addresses the prevention and control of hepatitis C virus (HCV) infection and its consequences. This strategy strives to protect the public's health by outlining guidelines for prevention and control of HCV infection, providing credible information on hepatitis C to enhance healthy decisions and promoting healthy living through strong partnerships with national, state, and local organizations in both the public and private sectors.

This report examines how children become infected with HIV, how infection can be prevented in children, and ways of reducing the impact of HIV. The report discusses statistics and data concerning pediatric HIV/AIDS, transmission; prevention, including health education and prevention of HIV in women of childbearing age and of unintended pregnancies in HIV-positive women and women at risk; and treatment.

This brochure describes PATH's national TB programs to expand DOTS. It was created for a global meeting on TB in Paris, Oct./Nov. 2004.

This pamphlet uses a question and answer format to provide information on TB infection, how it is transmitted and diagnosed, what to do when a skin test is positive, and what a person needs to know about TB medicines.

This poem was written for World TB Day 2007 to convey messages of commitment and hope in the efforts to eliminate TB. It captures the essence of the TB program's mission and dedication to the communities it serves.

This fact sheet describes general information regarding extensively drug-resistant TB.

This pamphlet uses a question and answer format to provide information on the bacille Calmette-Guerin (BCG) vaccine for TB. It discusses skin test results in relation to the BCG vaccine and treatment.

This information sheet discusses physician prescription of sterile syringes to injection drug users (IDUs) who continue to inject, in order to prevent the acquisition and transmission of HIV and other blood-borne diseases. Physician prescription of sterile syringes will not only help IDUs receive sterile syringes legally, but also can create links to other health care and social services that IDUs would not normally seek out. The example is given of a progam in Rhode Island that is examining the feasiblity of physician prescription in a community setting.

General information about what is tuberculosis (TB), the difference between LTBI and active TB, and how to get tested for TB.

This report provides an overview of various anti-TB medications.